As of 2025-07-16, the Relative Valuation of Taysha Gene Therapies Inc (TSHA) is (8.63) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.51 USD, the upside of Taysha Gene Therapies Inc based on Relative Valuation is -443.8%.
The range of the Relative Valuation is (5.54) - (10.71) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.1x - 26.5x | 19.8x |
| Forward P/E multiples | 13.7x - 32.1x | 22.9x |
| Fair Price | (5.54) - (10.71) | (8.63) |
| Upside | -320.6% - -526.7% | -443.8% |
| Date | P/E |
| 2025-07-14 | -6.53 |
| 2025-07-11 | -6.53 |
| 2025-07-10 | -6.31 |
| 2025-07-09 | -6.28 |
| 2025-07-08 | -5.99 |
| 2025-07-07 | -5.79 |
| 2025-07-03 | -6.06 |
| 2025-07-02 | -6.01 |
| 2025-07-01 | -5.79 |
| 2025-06-30 | -5.71 |
| 2025-06-27 | -5.89 |
| 2025-06-26 | -5.96 |
| 2025-06-25 | -6.04 |
| 2025-06-24 | -5.86 |
| 2025-06-23 | -6.16 |
| 2025-06-20 | -6.09 |
| 2025-06-18 | -6.36 |
| 2025-06-17 | -6.31 |
| 2025-06-16 | -6.33 |
| 2025-06-13 | -6.28 |
| 2025-06-12 | -6.56 |
| 2025-06-11 | -6.61 |
| 2025-06-10 | -6.46 |
| 2025-06-09 | -6.93 |
| 2025-06-06 | -7.03 |
| 2025-06-05 | -7.13 |
| 2025-06-04 | -6.90 |
| 2025-06-03 | -6.88 |
| 2025-06-02 | -6.89 |
| 2025-05-30 | -6.70 |
| 2025-05-29 | -6.80 |
| 2025-05-28 | -6.04 |
| 2025-05-27 | -6.44 |
| 2025-05-23 | -6.80 |
| 2025-05-22 | -7.05 |
| 2025-05-21 | -7.15 |
| 2025-05-20 | -7.25 |
| 2025-05-19 | -6.90 |
| 2025-05-16 | -6.68 |
| 2025-05-15 | -6.33 |
| 2025-05-14 | -5.86 |
| 2025-05-13 | -5.79 |
| 2025-05-12 | -5.74 |
| 2025-05-09 | -5.27 |
| 2025-05-08 | -5.20 |
| 2025-05-07 | -4.70 |
| 2025-05-06 | -4.95 |
| 2025-05-05 | -6.09 |
| 2025-05-02 | -6.38 |
| 2025-05-01 | -5.96 |